Trademarkia Logo

Canada

C$
LNP-SORT
SEARCHED

on 18 Dec 2024

Last Applicant/ Owned by

ReCode Therapeutics, Inc.

1455 Adams DriveSuite 1120Menlo Park, CA 94025

US

Serial Number

2126119 filed on 10th Aug 2021

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

LNP-SORT

Trademark usage description

medicines for the modification of genes and treatment of diseases; cell and gene therapy products including products with protein expression; drug car Read More

Classification Information


Class [005]
Medicines for the modification of genes and treatment of diseases; cell and gene therapy products including products with protein expression; drug carriers for medical use, namely, non-viral lipid nanoparticles for delivering drugs to human organs


Classification kind code

11

Class [041]
Providing information in the fields of genetic medicine and drug delivery


Classification kind code

11

Class [042]
Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases


Classification kind code

11

Class [044]
Medical and veterinary, beauty, agricultural and forestry


Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details


Serial Number

2126119

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 18th Dec 2024
Search Recorded
Submitted for opposition 20
on 18th Dec 2024
Examiner's First Report
Submitted for opposition 287
on 27th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 287
on 26th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 10th Aug 2021
Filed
Submitted for opposition 1
on 10th Aug 2021
Created
Submitted for opposition 31
on 10th Aug 2021
Formalized